What Are Some Emerging Trends In The Targeted Alpha-Therapy Market? Several leading businesses in the targeted alpha-therapy market are concentrating their efforts on creating novel solutions like ...

Psychological stress can impair the brain’s reward system, contributing to psychiatric disorders. A new study examines how a ...

Early research suggests a brain test may predict whether antidepressants will cause sexual dysfunction. There has never been ...

Lilly to present new clinical data for Verzenio and multiple novel pipeline programMEs at the 2025 ESMO annual meeting: Indianapolis Tuesday, October 14, 2025, 09:00 Hrs [IST] Eli ...

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

FDA grants orphan drug designation to cintredekin besudotox, offering new hope for glioblastoma treatment with targeted ...

Immatics is advancing Anzu-cel, a T-cell receptor therapy for melanoma with potential for significant annual revenue. Learn ...

The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this ...

Sanofi reports that its AlphaMedix phase 2 trial showed strong efficacy and survival benefits in gastroenteropancreatic ...

AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors ...

AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in ...